News & Press Releases
Filter by:
Mintz Advises on Capricor Therapeutics’ $150 Million Public Offering
December 10, 2025
Mintz advised the underwriters in connection with Capricor Therapeutics’ $150 million public offering.
Mintz Advises Relation Therapeutics on Additional Funding Round, Including Strategic Investment from Novartis
December 09, 2025
Mintz advised Relation Therapeutics, a technology-enabled biopharmaceutical company, on its strategic collaboration with Novartis, leading on the negotiation of an equity investment from Novartis.
Mintz’s Tara Dunn Jackson Named to Massachusetts Lawyers Weekly’s 2025 Top Women of Law
December 04, 2025
Mintz Associate Tara Dunn Jackson has been named to Massachusetts Lawyers Weekly’s 2025 Top Women of Law list, which honors the achievements of exceptional women lawyers who are pioneers, educators, trailblazers, and role models. The honorees were recognized at a ceremony hosted by Massachusetts Lawyers Weekly in November.
11 Mintz Intellectual Property Attorneys Named 2026 IAM Strategy 300 Global Leaders
November 24, 2025
Eleven Mintz attorneys have been featured in the 2026 edition of the Intellectual Asset Management (IAM) Strategy 300 Global Leaders Guide. This annual guide honors professionals whose peers regard their approach to intellectual property as “truly strategic in nature” and who demonstrate a “wealth of expertise across disciplines and sectors,” according to IAM.
Mintz advised the underwriters in connection with Cogent Biosciences, Inc.’s concurrent public offerings of $345 million of common stock (the “Equity Offering”) and $230 million in aggregated principal amount of 1.625% convertible senior notes due 2031 (the “Convertible Notes Offering”).
Mintz Advises on Verastem Oncology’s $103 Million Public Offering
November 21, 2025
Mintz advised the underwriters in connection with Verastem Oncology’s $103 million public offering.
